Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

Richard E. Royal, Catherine Lévy, Keli Turner, +8

Journal of Immunotherapy

ImmunologyPathologyPharmacotherapyImmunotherapeuticsImmunotherapy +15

Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy

Richard A. Morgan, Nachimuthu Chinnasamy, Daniel Abate‐Daga, +28

Journal of Immunotherapy

Generation of Tumor-Infiltrating Lymphocyte Cultures for Use in Adoptive Transfer Therapy for Melanoma Patients

Mark E. Dudley, John R. Wunderlich, Thomas E. Shelton, +2

Journal of Immunotherapy

Specific ReactivityCell TherapyImmunologyImmune Cell TherapyImmunotherapy +16

Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis

James Chih‐Hsin Yang, Marybeth S. Hughes, Udai S. Kammula, +10

Journal of Immunotherapy

Renal PathologyImmunologyPathologyImmunotherapeuticsCohort Response Rates +17

Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer

Dung T. Le, Eric R. Lutz, Jennifer N. Uram, +8

Journal of Immunotherapy

ImmunologyGm-csf GeneImmune Cell TherapyImmunotherapyCancer Biology +17

Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b

John Craddock, An Lu, Adham S. Bear, +4

Journal of Immunotherapy

Activated T CellsCancer ImmunosurveillanceEnhanced Tumor TraffickingCell TraffickingImmunology +12

IL-7 Administration to Humans Leads to Expansion of CD8+ and CD4+ Cells but a Relative Decrease of CD4+ T-Regulatory Cells

Steven A. Rosenberg, Claude Sportès, Mojgan Ahmadzadeh, +10

Journal of Immunotherapy

Il-7 AdministrationCd4+ CellsT-regulatory CellImmune RegulationImmunology +16

Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen Receptor

James N. Kochenderfer, Steven A. Feldman, Yangbing Zhao, +5

Journal of Immunotherapy

PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors

Kevin C. Soares, Agnieszka A. Rucki, Annie A. Wu, +15

Journal of Immunotherapy

Pd-1/pd-l1 Blockade TogetherPd-l1 Antibody TherapyTumor ImmunologyLigand Pd-l1Pancreatic Cancer +12

Induction of Cytokine Production from Human Monocytes Stimulated with Alginate

Marit Otterlei, Kjetill Østgaard, Gudmund Skjåk‐Bræk, +3

Journal of Immunotherapy